Ori Biotech

📍 London, United Kingdom🗓 Founded 2015👥 86 employees💰 Last funded Jun 2024
Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.
10
Total investors
3
Early stage
6
Mid stage
1
Late stage
2015
Founded
Investor geography1 country
United Kingdom
10
Investor activity2016–2024 · investors recorded per year
2016220171201932020320241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ori Biotech?
Ori Biotech has 10 investors on record on gritt.io, including 3 early-stage backers, 6 mid-stage and 1 late-stage investors.
When did Ori Biotech last raise funding?
The most recent investment in Ori Biotech recorded on gritt.io was in June 2024.
When was Ori Biotech founded?
Ori Biotech was founded in 2015.
What industry is Ori Biotech in?
Ori Biotech operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Ori Biotech based?
Ori Biotech is headquartered in London, United Kingdom.